David E. Lanar

7.7k total citations
88 papers, 4.6k citations indexed

About

David E. Lanar is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, David E. Lanar has authored 88 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Public Health, Environmental and Occupational Health, 40 papers in Immunology and 24 papers in Molecular Biology. Recurrent topics in David E. Lanar's work include Malaria Research and Control (62 papers), Mosquito-borne diseases and control (42 papers) and Complement system in diseases (23 papers). David E. Lanar is often cited by papers focused on Malaria Research and Control (62 papers), Mosquito-borne diseases and control (42 papers) and Complement system in diseases (23 papers). David E. Lanar collaborates with scholars based in United States, Kenya and United Kingdom. David E. Lanar's co-authors include Kevin C. Kain, Sheetij Dutta, David J. Conway, Edward J. Pearce, Stephanie L. James, Alan Sher, Arnoldo Barbosa, Kevin Marsh, Lisa A. Ware and Peter Burkhard and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

David E. Lanar

88 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Lanar United States	42	3.2k	1.5k	1.3k	964	625	88	4.6k
Sanjai Kumar United States	39	2.6k 0.8×	1.7k 1.1×	1.4k 1.1×	846 0.9×	600 1.0×	125	4.6k
Michael R. Hollingdale United States	36	3.7k 1.2×	1.7k 1.1×	2.1k 1.6×	843 0.9×	689 1.1×	106	5.4k
Takafumi Tsuboi Japan	45	5.1k 1.6×	2.2k 1.4×	1.6k 1.2×	1.4k 1.5×	698 1.1×	228	6.4k
David L. Narum United States	41	3.6k 1.1×	2.0k 1.3×	1.2k 0.9×	675 0.7×	512 0.8×	124	4.8k
Elizabeth Nardin United States	37	2.7k 0.8×	1.6k 1.0×	1.9k 1.4×	463 0.5×	667 1.1×	74	4.3k
Christian F. Ockenhouse United States	44	3.8k 1.2×	2.0k 1.3×	1.5k 1.2×	678 0.7×	910 1.5×	91	5.7k
Clemens H. M. Kocken Netherlands	40	3.7k 1.2×	1.6k 1.0×	1.1k 0.9×	1.1k 1.1×	701 1.1×	117	4.9k
Yupin Charoenvit United States	35	2.4k 0.8×	1.9k 1.2×	1.9k 1.4×	429 0.4×	698 1.1×	65	4.5k
Mary R. Galinski United States	38	4.1k 1.3×	1.5k 1.0×	938 0.7×	1.1k 1.2×	430 0.7×	111	4.9k
David J. Kemp Australia	43	2.7k 0.8×	1.0k 0.7×	1.5k 1.1×	1.2k 1.2×	615 1.0×	91	5.2k

Countries citing papers authored by David E. Lanar

Since Specialization

Citations

This map shows the geographic impact of David E. Lanar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Lanar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Lanar more than expected).

Fields of papers citing papers by David E. Lanar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Lanar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Lanar. The network helps show where David E. Lanar may publish in the future.

Co-authorship network of co-authors of David E. Lanar

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Lanar. A scholar is included among the top collaborators of David E. Lanar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Lanar. David E. Lanar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ubillos, Itziar, Alfons Jiménez, Marta Vidal, et al.. (2018). Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1–4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies. Malaria Journal. 17(1). 219–219. 8 indexed citations

2.

Bissati, Kamal El, Ying Zhou, Sara M. Paulillo, et al.. (2017). Protein nanovaccine confers robust immunity against Toxoplasma. npj Vaccines. 2(1). 24–24. 43 indexed citations

3.

Kaba, Stephen A., et al.. (2017). Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine. Vaccine. 36(6). 906–914. 42 indexed citations

4.

Keh, Chris, Aashish R. Jha, Bridget Nzarubara, et al.. (2012). Associations between Antibodies to a Panel of Plasmodium falciparum Specific Antigens and Response to Sub-Optimal Antimalarial Therapy in Kampala, Uganda. PLoS ONE. 7(12). e52571–e52571. 7 indexed citations

5.

Greenhouse, Bryan, Alan Hubbard, Denise Njama‐Meya, et al.. (2011). Antibodies to Plasmodium falciparum Antigens Predict a Higher Risk of Malaria But Protection From Symptoms Once Parasitemic. The Journal of Infectious Diseases. 204(1). 19–26. 72 indexed citations

6.

Nicoll, William, John B. Sacci, Carlo Rodolfo, et al.. (2011). Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase. Malaria Journal. 10(1). 14–14. 10 indexed citations

7.

Kaba, Stephen A., Clara Brando, Qin Guo, et al.. (2009). A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria. The Journal of Immunology. 183(11). 7268–7277. 132 indexed citations

8.

Dutta, Sheetij, JoAnn S. Sullivan, Katharine K. Grady, et al.. (2009). High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model. PLoS ONE. 4(12). e8138–e8138. 68 indexed citations

9.

Lyke, Kirsten E., Modibo Daou, Issa Diarra, et al.. (2009). Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: Results of a Phase I randomized trial. Vaccine. 27(15). 2171–2176. 12 indexed citations

10.

Osier, Faith, Greg Fegan, Spencer D. Polley, et al.. (2008). Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria. Infection and Immunity. 76(5). 2240–2248. 289 indexed citations

11.

Ned, Renée M., April E. Price, Sara Crawford, et al.. (2008). Effect of Placental Malaria and HIV Infection on the Antibody Responses toPlasmodium falciparumin Infants. The Journal of Infectious Diseases. 198(11). 1609–1619. 16 indexed citations

12.

Chelimo, Kiprotich, Ayub V. Ofulla, David L. Narum, et al.. (2005). Antibodies to Plasmodium falciparum Antigens Vary by Age and Antigen in Children in a Malaria-Holoendemic Area of Kenya. The Pediatric Infectious Disease Journal. 24(8). 680–684. 25 indexed citations

13.

Polley, Spencer D., Tabitha Mwangi, Clemens H. M. Kocken, et al.. (2004). Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine. 23(5). 718–728. 154 indexed citations

14.

Mirel, Lisa B., Feiko O. ter Kuile, OraLee H. Branch, et al.. (2003). The Effects of Varying Exposure to Malaria Transmission on Development of Antimalarial Antibody Responses in Preschool Children. XVI. Asembo Bay Cohort Project. The Journal of Infectious Diseases. 187(11). 1756–1764. 17 indexed citations

15.

Friedman, Jennifer F., et al.. (2003). Malaria Is Related to Decreased Nutritional Status among Male Adolescents and Adults in the Setting of Intense Perennial Transmission. The Journal of Infectious Diseases. 188(3). 449–457. 29 indexed citations

16.

Kolodny, Nelly, Svetlana Kitov, V. L. Miller, et al.. (2001). Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. Journal of Chromatography B. 762(1). 77–86. 1 indexed citations

17.

Kolodny, Nelly, Svetlana Kitov, V. L. Miller, et al.. (2001). Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. Journal of Chromatography B Biomedical Sciences and Applications. 762(1). 77–86. 12 indexed citations

18.

Kain, Kevin C., Arthur E. Brown, David E. Lanar, W R Ballou, & H. Kyle Webster. (1993). Response of Plasmodium Vivax Variants to Chloroquine as Determined by Microscopy and Quantitative Polymerase Chain Reaction. American Journal of Tropical Medicine and Hygiene. 49(4). 478–484. 29 indexed citations

19.

Kain, Kevin C., et al.. (1992). Serologic and Genetic Characterization of Plasmodium vivax from Whole Blood-Impregnated Filter Paper Discs. American Journal of Tropical Medicine and Hygiene. 46(4). 473–479. 27 indexed citations

20.

Kain, Kevin C., Jay Keystone, E D Franke, & David E. Lanar. (1991). Global Distribution of a Variant of the Circumsporozoite Gene of Plasmodium vivax. The Journal of Infectious Diseases. 164(1). 208–210. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact